The promise of adoptive cellular immunotherapies in hepatocellular carcinoma

Hepatocellular Carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide. Current systemic therapies result only in modest benefits and new therapeutic options are critically needed. Some patients show promising clinical responses to immune checkpoint inhibitors, however, ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendrickson, Peter G., Olson, Michael, Luetkens, Tim, Weston, Siani, Han, Tiffany, Atanackovic, Djordje, Fine, Gabriel C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959455/
https://www.ncbi.nlm.nih.gov/pubmed/32002284
http://dx.doi.org/10.1080/2162402X.2019.1673129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959455/
https://www.ncbi.nlm.nih.gov/pubmed/32002284
http://dx.doi.org/10.1080/2162402X.2019.1673129

Ejemplares similares